Tag: Aficamten

Stock

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress

18/05/2025
admin

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025…

Stock

Aficamten outperforms beta blocker in HCM trial

13/05/2025
admin

Aficamten outperforms beta blocker in HCM trial#Aficamten #outperforms #beta #blocker #HCM #trial

Stock

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China By Investing.com

20/12/2024
admin

SOUTH SAN FRANCISCO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) — Cytokinetics (NASDAQ:), Incorporated  (Nasdaq: CYTK) today…